Differential mRNA expression in ileal and colonic biopsies in irritable bowel syndrome with diarrhea or constipation

Michael Camilleri, Yorick Magnus, Paula Carlson, Xiao Jing Wang, Victor Chedid, Daniel Maselli, Ann Taylor, Sanna McKinzie, Nagaswaroop Kengunte Nagaraj, Irene Busciglio, Asha Nair

Research output: Contribution to journalArticlepeer-review


Altered mucosal functions are documented in jejunal or colorectal mucosa from patients with irritable bowel syndrome (IBS). Our aim was to quantify ileal, ascending, and rectosigmoid colon mucosal expression of genes in IBS-diarrhea (D) and IBS-constipation (C). Forty-four patients with IBS-D, 30 with IBS-C, and 30 healthy volunteers underwent colonoscopic ileal, ascending, and rectosigmoid colon biopsies. Biopsies were stored in RNAlater at -80°C, purified with on-column DNase, cDNA libraries prepared from 100–200 ng of total RNA, sequenced on Illumina NovaSeq 6000, and analyzed on Illumina’s RTA version 3.4.4. Normalized mRNA expression was obtained using MAP-RSeq bioinformatics pipeline. Differential expressions in the groups (Log2-fold change) were measured using the bioinformatics package edgeR 2.6.2, corrected for false discovery rate (PADJ <0.05). There were 30 females with IBS-C and 31 females and 13 males with IBS-D. In IBS-D and IBS-C groups, there were differential expressions of 181 genes in ascending colon and 199 genes in rectosigmoid colon. The majority were gene upregulations in IBS-D with functions reflecting activation of inflammation genes, TRPV1 (visceral hypersensitivity) and neurotransmitters/receptors (specifically purinergic, GABA, and cannabinoid). Although gene differential expressions in the ascending and rectosigmoid colon mucosa of the two groups were different, the diverse upregulated genes involved immune functions, receptors, transmitters, ion channels, and transporters. Conversely, there was reduced expression of PI15 and PI16 genes that inhibit proteases. In patients with IBS-D and IBS-C, differential expressions of genes related to immune, transmitter, nociceptive, protease inhibition, channel, and transporter functions suggest opportunities to reverse the pathobiology and treat patients with IBS.

Original languageEnglish (US)
Pages (from-to)G88-G101
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Issue number2
StatePublished - Aug 2022


  • TRPV1
  • gene
  • immune
  • receptor
  • transmitter

ASJC Scopus subject areas

  • Physiology
  • Hepatology
  • Gastroenterology
  • Physiology (medical)


Dive into the research topics of 'Differential mRNA expression in ileal and colonic biopsies in irritable bowel syndrome with diarrhea or constipation'. Together they form a unique fingerprint.

Cite this